Nath Bio-Genes (India) Ltd

BSE: 537291

total announcements

537291.BO · 15 min delayed

BSECompany Update▲ PositiveResults6d ago

Investor Presentation on Unaudited Financial Results as of 30th June 2026

Nath Bio-Genes (India) Ltd has announced its unaudited financial results for Q1FY27, showing a 15% increase in revenue to ₹3,228 Mn, a 13% increase in gross profit to ₹1,629 Mn, and a 17% increase in EBITDA to ₹351 Mn. The company has also reported a 12% increase in PAT to ₹327 Mn and a 12% increase in EPS to ₹17.18.

Outcome of Board Meeting: Unaudited Financial results as of 30th June 2026.

Nath Bio-Genes (India) Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with a net profit of Rs. 3265.68 lakhs and a revenue from operations of Rs. 32284.28 lakhs.

Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations

Nath Bio-Genes (India) Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming that securities received for dematerialization up to 30th June 2026 have been confirmed and listed on the stock exchange.